Skip to main content

Table 3 Association between metabolic syndromea and prostate cancer risk according to screening, age, ancestry and diabetes

From: Metabolic syndrome and prostate cancer risk in a population-based case–control study in Montreal, Canada

Strata characteristics N ORb 95 % CI
DRE screened in the last five years 3202   
 All cases   0.70 0.60-0.82
 Non aggressive cases   0.68 0.57-0.81
 Aggressive cases   0.75 0.60-0.95
Screened during the last two years 3387 0.62 0.50-0.78
Age at diagnosis (cases) / interview (controls)    
 < 65 years 1892 0.60 0.47-0.76
 ≥ 65 years 1986 0.79 0.64-0.96
Ancestry    
 Sub-Saharan 217 0.80 0.36-1.78
 Other (including European, Greater Middle East, Asiatic and Latino ancestries) 3650 0.70 0.60-0.82
Type 2 diabetes    
 No 3340 0.80 0.67-0.96
 Yes 551 0.67 0.44-1.01
  1. aAccording to the definition of the Adult Treatment Panel III from the National Cholesterol Education Program
  2. bAdjusted for age, family history of prostate cancer, ancestry, prostate cancer screening 2 years earlier, and family income
  3. CI, Confidence interval; DRE, Digital rectal examination; OR, Odds ratio